Tumor cell uptake values of 3.15% ± 0.04—measured at 2 h post-incubation—coupled with the suitable in vivo tumor accretion confirmed the affinity of [68Ga]Ga-DOTA-NKL for selective APN/CD13-positive tumor-homing. The gene discussed is GLIS2; the disease is neoplasm.